Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03328143Phase 1Completed
Phase 1, open-label trial in anxiety disorder and pain, sponsored by Wake Forest University Health Sciences. Primary endpoints: Number of Consented Patients and Protocol Completion. Started Apr 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03328143.